Abstract
In vitro activities of DA-7867, a novel oxazolidinone, were compared to those of linezolid and commonly used antimicrobials. DA-7867 had the lowest MIC for 90% of the aerobic gram-positive bacterial strains tested, ≤0.25 μg/ml, and it was more potent than linezolid.
| Original language | English |
|---|---|
| Pages (from-to) | 352-357 |
| Number of pages | 6 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 48 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2004 Jan |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Fingerprint Dive into the research topics of 'In Vitro Activities of DA-7867, a Novel Oxazolidinone, against Recent Clinical Isolates of Aerobic and Anaerobic Bacteria'. Together they form a unique fingerprint.
Cite this
Yong, D., Yum, J. H., Lee, K., Chong, Y., Choi, S. H., & Rhee, J. K. (2004). In Vitro Activities of DA-7867, a Novel Oxazolidinone, against Recent Clinical Isolates of Aerobic and Anaerobic Bacteria. Antimicrobial agents and chemotherapy, 48(1), 352-357. https://doi.org/10.1128/AAC.48.1.352-357.2004